Skip to main content
Clinical Trials/NCT04714528
NCT04714528
Active, not recruiting
Not Applicable

Physical Activity as Treatment for Depression and Anxiety Towards Affordable Preventive Healthcare - a Randomised Controlled Study (RCT)

Region Örebro County1 site in 1 country87 target enrollmentOctober 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Depression
Sponsor
Region Örebro County
Enrollment
87
Locations
1
Primary Endpoint
Symptom improvement in anxiety
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

In a 12 week randomly controlled open trial 102 participants with symptoms of depression and/or anxiety will be exposed to either aerobic high intensity training (HIT) or relaxation therapy. Cognitive functions, biomarkers, psychiatric symptom scales and physical status will be collected at baseline, after 12 weeks and after a year. Depression and anxiety will be measured twice during the intervention period.

Registry
clinicaltrials.gov
Start Date
October 1, 2020
End Date
December 31, 2026
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Region Örebro County
Responsible Party
Principal Investigator
Principal Investigator

Yvonne Freund-Levi

Associate Professor, M.D., Ph.D

Region Örebro County

Eligibility Criteria

Inclusion Criteria

  • Score ≥12 on MADRS or score ≥16 on BAI
  • Inhabitant i Örebro County, Sweden
  • BMI ≥18 kg/m\^2

Exclusion Criteria

  • Diagnosis of chronic psychotic disease or ongoing psychotic episode.
  • Ongoing manic state of bipolar disorder
  • Severe somatic disease or condition where high intensity exercise is contraindicated
  • Difficulty with reading, hearing or understanding the Swedish language

Outcomes

Primary Outcomes

Symptom improvement in anxiety

Time Frame: Change of the score from the baseline to the score at 1 year.

Improvement of symptom severity grade are assessed with Beck Anxiety Inventory (BAI). The minimum and the maximum score is 0 and 63 respectively, and the higher score means a worse outcome.

Symptom improvement in depression

Time Frame: Change of the score from the baseline to the score at 1 year.

Improvement of symptom severity grade are assessed with Montgomery-Åsberg Depression Rating Scale (MADRS). The minimum and the maximum score is 0 and 60 respectively, and the higher score means a worse outcome.

Subjective symptom improvement in depression

Time Frame: Change of the score from the baseline to the score at 1 year.

Improvement of symptom severity grade are assessed with Montgomery-Åsberg Depression Rating Scale Self-Rating Version (MADRS-S). The minimum and the maximum score is 0 and 60 respectively, and the higher score means a worse outcome.

Secondary Outcomes

  • Cognitive function: Trail Making Test Part A&B(Comparison of results between baseline and year 1.)
  • Cognitive function: Corsi Block-Tapping Test forward(Comparison of results between baseline and year 1.)
  • Cognitive function: Rey Auditory Verbal Learning Test(Comparison of results between baseline and year 1.)
  • Cognitive function: Stroop test(Comparison of results between baseline and year 1.)
  • Clinical Global Impression (CGI) severity scale(Up to 1 year from baseline.)
  • EuroQol-Health-Related Quality of Life (EQ-5D-5L)(Up to 1 year from baseline.)
  • Posttraumatic Stress Disorder Checklist (PCL-5)(Up to 1 year from baseline.)
  • Adult ADHD Self-Report Scale (ASRS)(Up to 1 year from baseline.)
  • Cognitive function: Symbol Digit Modalities Test(Comparison of results between baseline and year 1.)
  • Perceived Stress Scale (PSS-14)(Up to 1 year from baseline.)

Study Sites (1)

Loading locations...

Similar Trials